Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus
- Puoti, M.a, Lorenzini, P.b, Cozzi-Lepri, A.c, Gori, A.d, Mastroianni, C.e, Rizzardini, G.f, Mazzarello, G.g, Antinori, A.b, d'Arminio Monforte, A.h, Girardi, E.bEmail Author, d'Arminio Monforte, A.i, Andreoni, M.j, Angarano, G.k, Antinori, A.l, Castelli, F.m, Cauda, R.n, Di Perri, G.o, Galli, M.p, Iardino, R.q, Ippolito, G.r, Lazzarin, A.s, Perno, C.F.t, von Schloesser, F.u, Viale, P.v, Castagna, A.w, Ceccherini-Silberstein, F.x, Cozzi-Lepri, A.y, Girardi, E.z, Lo Caputo, S.aa, Mussini, C.ab, Puoti, M.ac, Andreoni, M.ad, Ammassari, A.ae, Balotta, C.af, Bandera, A.ag, Bonfanti, P.ah, Bonora, S.ai, Borderi, M.aj, Calcagno, A.ak, Calza, L.al, Capobianchi, M.R.am, Castagna, A.an, Ceccherini-Silberstein, F.ao, Cingolani, A.ap, Cinque, P.aq, De Luca, A.ar, Di Biagio, A.as, Gianotti, N.at, Gori, A.au, Guaraldi, G.av, Lapadula, G.aw, Lichtner, M.ax, Lo Caputo, S.ay, Madeddu, G.az, Maggiolo, F.ba, Marchetti, G.bb, Marcotullio, S.bc, Monno, L.bd, Mussini, C.be, Nozza, S.bf, Quiros Roldan, E.bg, Rossotti, R.bh, Rusconi, S.bi, Santoro, M.M.bj, Saracino, A.bk, Zaccarelli, M.bl, Fanti, I.bm, Galli, L.bn, Lorenzini, P.bo, Rodano, A.bp, Shanyinde, M.bq, Tavelli, A.br, Carletti, F.bs, Carrara, S.bt, Di Caro, A.bu, Graziano, S.bv, Petrone, F.bw, Prota, G.bx, Quartu, S.by, Truffa, S.bz, Giacometti, I.A.ca, Costantini, A.cb, Valeriani, C.cc, Angarano, G.cd, Monno, L.ce, Santoro, C.cf, Maggiolo, F.cg, Suardi, C.ch, Viale, P.ci, Donati, V.cj, Verucchi, G.ck, Castelli, F.cl, Quiros Roldan, E.cm, Minardi, C.cn, Quirino, T.co, Abeli, C.cp, Manconi, P.E.cq, Piano, P.cr, Cacopardo, B.cs, Celesia, B.ct, Vecchiet, J.cu, Falasca, K.cv, Sighinolfi, L.cw, Segala, D.cx, Mazzotta, F.cy, Vichi, F.cz, Cassola, G.da, Viscoli, C.db, Alessandrini, A.dc, Bobbio, N.dd, Mazzarello, G.de, Mastroianni, C.df, Belvisi, V.dg, Bonfanti, P.dh, Caramma, I.di, Chiodera, A.dj, Castelli, A.P.dk, Galli, M.dl, Lazzarin, A.dm, Rizzardini, G.dn, Ridolfo, A.L.do, Piolini, R.dp, Castagna, A.dq, Salpietro, S.dr, Carenzi, L.ds, Moioli, M.C.dt, Tincati, C.du, Marchetti, G.dv, Mussini, C.dw, Puzzolante, C.dx, Lapadula, G.dy, Abrescia, N.dz, Chirianni, A.ea, Borgia, G.eb, Di Martino, F.ec, Maddaloni, L.ed, Gentile, I.ee, Orlando, R.ef, Baldelli, F.eg, Francisci, D.eh, Parruti, G.ei, Ursini, T.ej, Magnani, G.ek, Ursitti, M.A.el, Cauda, R.em, Andreoni, M.en, Vullo, V.eo, Cristaudo, A.ep, Cingolani, A.eq, Baldin, G.er, Cicalini, S.es, Gallo, L.et, Nicastri, E.eu, Acinapura, R.ev, Capozzi, M.ew, Libertone, R.ex, Savinelli, S.ey, Latini, A.ez, Iaiani, G.fa, Fontanelli Sulekova, L.fb, Cecchetto, M.fc, Viviani, F.fd, Mura, M.S.fe, Madeddu, G.ff, De Luca, A.fg, Rossetti, B.fh, Caramello, P.fi, Di Perri, G.fj, Orofino, G.C.fk, Bonora, S.fl, Sciandra, M
- Bassetti, M.
- Londero, A.fo, Pellizzer, G.fp, Manfrin, V.fq
DOIAbstract
Objective: To estimate the incidence of hepatitis C virus (HCV) seroconversion and the risk of severe fibrosis/cirrhosis in HCV seroconverters among persons with human immunodeficiency virus (HIV) infection. Methods: We analysed data on 4059 persons with HIV enrolled in a cohort study in Italy. Results: Incidence rate of seroconversion was 0.6/100 person-years overall, and drug users and menwho-have-sex-with-men were at highest risk. The cumulative risk of progression to severe fibrosis/cirrhosis was 30% by 10 years after seroconversion. Conclusions: New HCV infections have a rapidly progressive course in this population. Persons with HIV and HCV superinfection should be prioritized for treatment with anti-HCV direct-acting antivirals
Add to ORKG